CVE-2026-44955: Pronetiqs Panduit Intravue

Medium severity, CVSS 5.3. EPSS: 0.3% chance of exploitation in the next 30 days.

Pronetiqs IntraVUE versions 3.2.1a14 and prior have an exposure of sensitive system information to an unauthorized control sphere vulnerability which could allow for asset discovery by unauthenticated users.

Affected products

• Pronetiqs Panduit Intravue: up to and including 3.2.1a14

Published 2026-07-23. Last modified 2026-07-27.